Clinical Trial Update: Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating voriconazole with or without interferon-gamma in patients with aspergillosis and other fungal infections; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Fungal Infections

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)
• Vfend (voriconazole) (voriconazole)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Infection, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Status: COMPLETED